欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/2598/002
药品名称	Eudorlin Ibuprofen 40 mg/ml Suspension zum Einnehmen
活性成分	ibuprofen 40.0 mg/ml
剂型	Oral suspension
上市许可持有人	Berlin-Chemie AG Glienicker Weg 125 D-12489 Berlin
参考成员国 - 产品名称	Germany (DE) Ibuprofen LIDERFARM 200 mg/5 ml, Suspension zum Einnehmen
互认成员国 - 产品名称	Bulgaria (BG) MIG Junior Estonia (EE) IBUSTAR FORTE Lithuania (LT) Ibustar 40 mg/ml geriamoji suspensija, vaikams Latvia (LV) Ibustar bērniem 200 mg/5 ml suspensija iekšķīgai lietošanai Croatia (HR) Slovakia (SK) MIG 4% Poland (PL)
许可日期	2011/12/02
最近更新日期	2023/12/12
药物ATC编码	M01AE01 ibuprofen
申请类型	TypeLevel1：Abridged TypeLevel2：Additional Strength/Form TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Non Prescription (including OTC)
附件文件下载	Final PL \| DE_H_2598_002_WS_1192_Ibuprofen_FINAL_PI_cvDate of last change:2023/11/24 Final SPC \| DE_H_2598_002_WS_1192_Ibuprofen_FINAL_SmPC_cvDate of last change:2023/11/24 Final Labelling \| DE_2598_Ibuprofen Liderfarm (OTC)_IP_clv_20160919_renewalDate of last change:2016/12/30 Final Labelling \| DE_2598_Ibuprofen Liderfarm (OTC)_OP_clv_20160919_renewalDate of last change:2016/12/30 Final Product Information \| common-final-labip-2598-OTCDate of last change:2015/12/04 Final Product Information \| common-final-labip-2598-RXDate of last change:2015/12/04 Final Product Information \| common-final-labop-2598-OTCDate of last change:2015/12/04 Final Product Information \| common-final-labop-2598-RXDate of last change:2015/12/04 Final Product Information \| common-final-pl-2598-OTCDate of last change:2015/12/04 Final Product Information \| common-final-pl-2598-RXDate of last change:2015/12/04 Final Product Information \| common-final-spc-2598Date of last change:2015/12/04 PAR \| PAREN-DE2597-2598_IbuprofenDate of last change:2015/08/12
市场状态	Positive